Skip to main content

Published locations for Efficacy and safety of lowering dupilumab frequency for AD

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Efficacy and safety of lowering dupilumab frequency for AD

User login

  • Reset your password
  • /content/efficacy-and-safety-lowering-dupilumab-frequency-ad
  • /edermatologynews/article/214995/atopic-dermatitis/efficacy-and-safety-lowering-dupilumab-frequency
  • /pediatricnews/article/214995/atopic-dermatitis/efficacy-and-safety-lowering-dupilumab-frequency-ad
  • /pediatrics/article/214995/atopic-dermatitis/efficacy-and-safety-lowering-dupilumab-frequency-ad
  • /dermatology/article/214995/atopic-dermatitis/efficacy-and-safety-lowering-dupilumab-frequency-ad